Viral-based knockdown of Fbxo2 in PFC restores NMDAR-EPSC, leading to the amelioration of cognitive deficits, further confirming the important role of Smyd3-Fbxo2-NR1 pathway in AD pathophysiology. This evidence concerns the gene SMYD3 and Cognitive impairment.